Click for best price
Hepatitis B Human Immunoglobulin Market Size, Share 2022
Market Analysis and Insights: Global Hepatitis B Human Immunoglobulin Market
The global Hepatitis B Human Immunoglobulin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis B Human Immunoglobulin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis B Human Immunoglobulin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis B Human Immunoglobulin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis B Human Immunoglobulin market.
Global Hepatitis B Human Immunoglobulin Scope and Market Size
Hepatitis B Human Immunoglobulin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Hepatitis B Human Immunoglobulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
100IU
200IU
400IU
Segment by Application
Measles Prevention
Prevention of Hepatitis B Virus Infection
Hepatitis A Virus Infection
Other
By Company
Biotest
ADMA Biologics
Sanquin Blood
Bio Products Laboratory
Baxter
CSL
Bayer
Grifols
Octapharma
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Shanghai Institute of Biological
Hualan
Shanghai RAAS Blood Products
China Grand Enterprises
Nanyue Biopharmaceutical
Boya Biopharmaceutical Group
Tonglu Biopharmaceutical
Shandong Taibang Biopharmaceutical
Guangdong Shuanglin Biopharmaceutical
Chengdu Rongsheng Pharmaceutical
Shenzhen Weiguang Biopharmaceutical
Green Cross (China) Biological Products
Sinopharm
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Hepatitis B Human Immunoglobulin product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Hepatitis B Human Immunoglobulin, with price, sales, revenue, and global market share of Hepatitis B Human Immunoglobulin from 2019 to 2022.
Chapter 3, the Hepatitis B Human Immunoglobulin competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hepatitis B Human Immunoglobulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Hepatitis B Human Immunoglobulin market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hepatitis B Human Immunoglobulin.
Chapter 13, 14, and 15, to describe Hepatitis B Human Immunoglobulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Hepatitis B Human Immunoglobulin Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Hepatitis B Human Immunoglobulin Market Insights and Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
126 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Hepatitis B Human Immunoglobulin Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 100IU
1.2.3 200IU
1.2.4 400IU
1.3 Market by Application
1.3.1 Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Measles Prevention
1.3.3 Prevention of Hepatitis B Virus Infection
1.3.4 Hepatitis A Virus Infection
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis B Human Immunoglobulin Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis B Human Immunoglobulin Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis B Human Immunoglobulin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis B Human Immunoglobulin Sales by Region
2.4.1 Global Hepatitis B Human Immunoglobulin Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis B Human Immunoglobulin by Region (2023-2028)
2.5 Global Hepatitis B Human Immunoglobulin Revenue by Region
2.5.1 Global Hepatitis B Human Immunoglobulin Revenue by Region (2017-2022)
2.5.2 Global Hepatitis B Human Immunoglobulin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis B Human Immunoglobulin Sales by Manufacturers
3.1.1 Global Top Hepatitis B Human Immunoglobulin Manufacturers by Sales (2017-2022)
3.1.2 Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Human Immunoglobulin in 2021
3.2 Global Hepatitis B Human Immunoglobulin Revenue by Manufacturers
3.2.1 Global Hepatitis B Human Immunoglobulin Revenue by Manufacturers (2017-2022)
3.2.2 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Human Immunoglobulin Revenue in 2021
3.3 Global Hepatitis B Human Immunoglobulin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis B Human Immunoglobulin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis B Human Immunoglobulin Sales by Type
4.1.1 Global Hepatitis B Human Immunoglobulin Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis B Human Immunoglobulin Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis B Human Immunoglobulin Revenue by Type
4.2.1 Global Hepatitis B Human Immunoglobulin Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis B Human Immunoglobulin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis B Human Immunoglobulin Price by Type
4.3.1 Global Hepatitis B Human Immunoglobulin Price by Type (2017-2022)
4.3.2 Global Hepatitis B Human Immunoglobulin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hepatitis B Human Immunoglobulin Sales by Application
5.1.1 Global Hepatitis B Human Immunoglobulin Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis B Human Immunoglobulin Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis B Human Immunoglobulin Revenue by Application
5.2.1 Global Hepatitis B Human Immunoglobulin Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis B Human Immunoglobulin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis B Human Immunoglobulin Price by Application
5.3.1 Global Hepatitis B Human Immunoglobulin Price by Application (2017-2022)
5.3.2 Global Hepatitis B Human Immunoglobulin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hepatitis B Human Immunoglobulin Market Size by Type
6.1.1 North America Hepatitis B Human Immunoglobulin Sales by Type (2017-2028)
6.1.2 North America Hepatitis B Human Immunoglobulin Revenue by Type (2017-2028)
6.2 North America Hepatitis B Human Immunoglobulin Market Size by Application
6.2.1 North America Hepatitis B Human Immunoglobulin Sales by Application (2017-2028)
6.2.2 North America Hepatitis B Human Immunoglobulin Revenue by Application (2017-2028)
6.3 North America Hepatitis B Human Immunoglobulin Market Size by Country
6.3.1 North America Hepatitis B Human Immunoglobulin Sales by Country (2017-2028)
6.3.2 North America Hepatitis B Human Immunoglobulin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis B Human Immunoglobulin Market Size by Type
7.1.1 Europe Hepatitis B Human Immunoglobulin Sales by Type (2017-2028)
7.1.2 Europe Hepatitis B Human Immunoglobulin Revenue by Type (2017-2028)
7.2 Europe Hepatitis B Human Immunoglobulin Market Size by Application
7.2.1 Europe Hepatitis B Human Immunoglobulin Sales by Application (2017-2028)
7.2.2 Europe Hepatitis B Human Immunoglobulin Revenue by Application (2017-2028)
7.3 Europe Hepatitis B Human Immunoglobulin Market Size by Country
7.3.1 Europe Hepatitis B Human Immunoglobulin Sales by Country (2017-2028)
7.3.2 Europe Hepatitis B Human Immunoglobulin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis B Human Immunoglobulin Market Size by Type
8.1.1 Asia Pacific Hepatitis B Human Immunoglobulin Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis B Human Immunoglobulin Market Size by Application
8.2.1 Asia Pacific Hepatitis B Human Immunoglobulin Sales by Application (2017-2028)
8.2.2 Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Application (2017-2028)
8.3 Asia Pacific Hepatitis B Human Immunoglobulin Market Size by Region
8.3.1 Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hepatitis B Human Immunoglobulin Market Size by Type
9.1.1 Latin America Hepatitis B Human Immunoglobulin Sales by Type (2017-2028)
9.1.2 Latin America Hepatitis B Human Immunoglobulin Revenue by Type (2017-2028)
9.2 Latin America Hepatitis B Human Immunoglobulin Market Size by Application
9.2.1 Latin America Hepatitis B Human Immunoglobulin Sales by Application (2017-2028)
9.2.2 Latin America Hepatitis B Human Immunoglobulin Revenue by Application (2017-2028)
9.3 Latin America Hepatitis B Human Immunoglobulin Market Size by Country
9.3.1 Latin America Hepatitis B Human Immunoglobulin Sales by Country (2017-2028)
9.3.2 Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis B Human Immunoglobulin Market Size by Type
10.1.1 Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis B Human Immunoglobulin Market Size by Application
10.2.1 Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Application (2017-2028)
10.3 Middle East and Africa Hepatitis B Human Immunoglobulin Market Size by Country
10.3.1 Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Biotest
11.1.1 Biotest Corporation Information
11.1.2 Biotest Overview
11.1.3 Biotest Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Biotest Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biotest Recent Developments
11.2 ADMA Biologics
11.2.1 ADMA Biologics Corporation Information
11.2.2 ADMA Biologics Overview
11.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 ADMA Biologics Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ADMA Biologics Recent Developments
11.3 Sanquin Blood
11.3.1 Sanquin Blood Corporation Information
11.3.2 Sanquin Blood Overview
11.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanquin Blood Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanquin Blood Recent Developments
11.4 Bio Products Laboratory
11.4.1 Bio Products Laboratory Corporation Information
11.4.2 Bio Products Laboratory Overview
11.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bio Products Laboratory Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio Products Laboratory Recent Developments
11.5 Baxter
11.5.1 Baxter Corporation Information
11.5.2 Baxter Overview
11.5.3 Baxter Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Baxter Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Baxter Recent Developments
11.6 CSL
11.6.1 CSL Corporation Information
11.6.2 CSL Overview
11.6.3 CSL Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CSL Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CSL Recent Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Overview
11.7.3 Bayer Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Grifols
11.8.1 Grifols Corporation Information
11.8.2 Grifols Overview
11.8.3 Grifols Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Grifols Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Grifols Recent Developments
11.9 Octapharma
11.9.1 Octapharma Corporation Information
11.9.2 Octapharma Overview
11.9.3 Octapharma Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Octapharma Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Octapharma Recent Developments
11.10 Hualan Biological
11.10.1 Hualan Biological Corporation Information
11.10.2 Hualan Biological Overview
11.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Hualan Biological Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Hualan Biological Recent Developments
11.11 China Biologic
11.11.1 China Biologic Corporation Information
11.11.2 China Biologic Overview
11.11.3 China Biologic Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 China Biologic Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 China Biologic Recent Developments
11.12 Tiantan Biologic
11.12.1 Tiantan Biologic Corporation Information
11.12.2 Tiantan Biologic Overview
11.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Tiantan Biologic Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Tiantan Biologic Recent Developments
11.13 Shuanglin Bio-pharmacy
11.13.1 Shuanglin Bio-pharmacy Corporation Information
11.13.2 Shuanglin Bio-pharmacy Overview
11.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shuanglin Bio-pharmacy Recent Developments
11.14 Sichuan Yuanda Shuyang
11.14.1 Sichuan Yuanda Shuyang Corporation Information
11.14.2 Sichuan Yuanda Shuyang Overview
11.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sichuan Yuanda Shuyang Recent Developments
11.15 Shanghai Institute of Biological
11.15.1 Shanghai Institute of Biological Corporation Information
11.15.2 Shanghai Institute of Biological Overview
11.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Shanghai Institute of Biological Recent Developments
11.16 Hualan
11.16.1 Hualan Corporation Information
11.16.2 Hualan Overview
11.16.3 Hualan Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Hualan Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Hualan Recent Developments
11.17 Shanghai RAAS Blood Products
11.17.1 Shanghai RAAS Blood Products Corporation Information
11.17.2 Shanghai RAAS Blood Products Overview
11.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Shanghai RAAS Blood Products Recent Developments
11.18 China Grand Enterprises
11.18.1 China Grand Enterprises Corporation Information
11.18.2 China Grand Enterprises Overview
11.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 China Grand Enterprises Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 China Grand Enterprises Recent Developments
11.19 Nanyue Biopharmaceutical
11.19.1 Nanyue Biopharmaceutical Corporation Information
11.19.2 Nanyue Biopharmaceutical Overview
11.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Nanyue Biopharmaceutical Recent Developments
11.20 Boya Biopharmaceutical Group
11.20.1 Boya Biopharmaceutical Group Corporation Information
11.20.2 Boya Biopharmaceutical Group Overview
11.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Boya Biopharmaceutical Group Recent Developments
11.21 Tonglu Biopharmaceutical
11.21.1 Tonglu Biopharmaceutical Corporation Information
11.21.2 Tonglu Biopharmaceutical Overview
11.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Tonglu Biopharmaceutical Recent Developments
11.22 Shandong Taibang Biopharmaceutical
11.22.1 Shandong Taibang Biopharmaceutical Corporation Information
11.22.2 Shandong Taibang Biopharmaceutical Overview
11.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Shandong Taibang Biopharmaceutical Recent Developments
11.23 Guangdong Shuanglin Biopharmaceutical
11.23.1 Guangdong Shuanglin Biopharmaceutical Corporation Information
11.23.2 Guangdong Shuanglin Biopharmaceutical Overview
11.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Guangdong Shuanglin Biopharmaceutical Recent Developments
11.24 Chengdu Rongsheng Pharmaceutical
11.24.1 Chengdu Rongsheng Pharmaceutical Corporation Information
11.24.2 Chengdu Rongsheng Pharmaceutical Overview
11.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Chengdu Rongsheng Pharmaceutical Recent Developments
11.25 Shenzhen Weiguang Biopharmaceutical
11.25.1 Shenzhen Weiguang Biopharmaceutical Corporation Information
11.25.2 Shenzhen Weiguang Biopharmaceutical Overview
11.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.25.4 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.25.5 Shenzhen Weiguang Biopharmaceutical Recent Developments
11.26 Green Cross (China) Biological Products
11.26.1 Green Cross (China) Biological Products Corporation Information
11.26.2 Green Cross (China) Biological Products Overview
11.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.26.4 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.26.5 Green Cross (China) Biological Products Recent Developments
11.27 Sinopharm
11.27.1 Sinopharm Corporation Information
11.27.2 Sinopharm Overview
11.27.3 Sinopharm Hepatitis B Human Immunoglobulin Sales, Price, Revenue and Gross Margin (2017-2022)
11.27.4 Sinopharm Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.27.5 Sinopharm Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis B Human Immunoglobulin Industry Chain Analysis
12.2 Hepatitis B Human Immunoglobulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis B Human Immunoglobulin Production Mode & Process
12.4 Hepatitis B Human Immunoglobulin Sales and Marketing
12.4.1 Hepatitis B Human Immunoglobulin Sales Channels
12.4.2 Hepatitis B Human Immunoglobulin Distributors
12.5 Hepatitis B Human Immunoglobulin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis B Human Immunoglobulin Industry Trends
13.2 Hepatitis B Human Immunoglobulin Market Drivers
13.3 Hepatitis B Human Immunoglobulin Market Challenges
13.4 Hepatitis B Human Immunoglobulin Market Restraints
14 Key Findings in The Global Hepatitis B Human Immunoglobulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 100IU
Table 3. Major Manufacturers of 200IU
Table 4. Major Manufacturers of 400IU
Table 5. Global Hepatitis B Human Immunoglobulin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Hepatitis B Human Immunoglobulin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Hepatitis B Human Immunoglobulin Sales by Region (2017-2022) & (Litre)
Table 8. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2017-2022)
Table 9. Global Hepatitis B Human Immunoglobulin Sales by Region (2023-2028) & (Litre)
Table 10. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2023-2028)
Table 11. Global Hepatitis B Human Immunoglobulin Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2017-2022)
Table 13. Global Hepatitis B Human Immunoglobulin Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2023-2028)
Table 15. Global Hepatitis B Human Immunoglobulin Sales by Manufacturers (2017-2022) & (Litre)
Table 16. Global Hepatitis B Human Immunoglobulin Sales Share by Manufacturers (2017-2022)
Table 17. Global Hepatitis B Human Immunoglobulin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Hepatitis B Human Immunoglobulin Revenue Share by Manufacturers (2017-2022)
Table 19. Hepatitis B Human Immunoglobulin Price by Manufacturers (2017-2022) &(US$/ML)
Table 20. Global Hepatitis B Human Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Hepatitis B Human Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Human Immunoglobulin as of 2021)
Table 22. Hepatitis B Human Immunoglobulin Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Hepatitis B Human Immunoglobulin Product Offered
Table 24. Date of Manufacturers Enter into Hepatitis B Human Immunoglobulin Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hepatitis B Human Immunoglobulin Sales by Type (2017-2022) & (Litre)
Table 27. Global Hepatitis B Human Immunoglobulin Sales by Type (2023-2028) & (Litre)
Table 28. Global Hepatitis B Human Immunoglobulin Sales Share by Type (2017-2022)
Table 29. Global Hepatitis B Human Immunoglobulin Sales Share by Type (2023-2028)
Table 30. Global Hepatitis B Human Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Hepatitis B Human Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Hepatitis B Human Immunoglobulin Revenue Share by Type (2017-2022)
Table 33. Global Hepatitis B Human Immunoglobulin Revenue Share by Type (2023-2028)
Table 34. Hepatitis B Human Immunoglobulin Price by Type (2017-2022) & (US$/ML)
Table 35. Global Hepatitis B Human Immunoglobulin Price Forecast by Type (2023-2028) & (US$/ML)
Table 36. Global Hepatitis B Human Immunoglobulin Sales by Application (2017-2022) & (Litre)
Table 37. Global Hepatitis B Human Immunoglobulin Sales by Application (2023-2028) & (Litre)
Table 38. Global Hepatitis B Human Immunoglobulin Sales Share by Application (2017-2022)
Table 39. Global Hepatitis B Human Immunoglobulin Sales Share by Application (2023-2028)
Table 40. Global Hepatitis B Human Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Hepatitis B Human Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Hepatitis B Human Immunoglobulin Revenue Share by Application (2017-2022)
Table 43. Global Hepatitis B Human Immunoglobulin Revenue Share by Application (2023-2028)
Table 44. Hepatitis B Human Immunoglobulin Price by Application (2017-2022) & (US$/ML)
Table 45. Global Hepatitis B Human Immunoglobulin Price Forecast by Application (2023-2028) & (US$/ML)
Table 46. North America Hepatitis B Human Immunoglobulin Sales by Type (2017-2022) & (Litre)
Table 47. North America Hepatitis B Human Immunoglobulin Sales by Type (2023-2028) & (Litre)
Table 48. North America Hepatitis B Human Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Hepatitis B Human Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Hepatitis B Human Immunoglobulin Sales by Application (2017-2022) & (Litre)
Table 51. North America Hepatitis B Human Immunoglobulin Sales by Application (2023-2028) & (Litre)
Table 52. North America Hepatitis B Human Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Hepatitis B Human Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Hepatitis B Human Immunoglobulin Sales by Country (2017-2022) & (Litre)
Table 55. North America Hepatitis B Human Immunoglobulin Sales by Country (2023-2028) & (Litre)
Table 56. North America Hepatitis B Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Hepatitis B Human Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Hepatitis B Human Immunoglobulin Sales by Type (2017-2022) & (Litre)
Table 59. Europe Hepatitis B Human Immunoglobulin Sales by Type (2023-2028) & (Litre)
Table 60. Europe Hepatitis B Human Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Hepatitis B Human Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Hepatitis B Human Immunoglobulin Sales by Application (2017-2022) & (Litre)
Table 63. Europe Hepatitis B Human Immunoglobulin Sales by Application (2023-2028) & (Litre)
Table 64. Europe Hepatitis B Human Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Hepatitis B Human Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Hepatitis B Human Immunoglobulin Sales by Country (2017-2022) & (Litre)
Table 67. Europe Hepatitis B Human Immunoglobulin Sales by Country (2023-2028) & (Litre)
Table 68. Europe Hepatitis B Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Hepatitis B Human Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Type (2017-2022) & (Litre)
Table 71. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Type (2023-2028) & (Litre)
Table 72. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Application (2017-2022) & (Litre)
Table 75. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Application (2023-2028) & (Litre)
Table 76. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2017-2022) & (Litre)
Table 79. Asia Pacific Hepatitis B Human Immunoglobulin Sales by Region (2023-2028) & (Litre)
Table 80. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Hepatitis B Human Immunoglobulin Sales by Type (2017-2022) & (Litre)
Table 83. Latin America Hepatitis B Human Immunoglobulin Sales by Type (2023-2028) & (Litre)
Table 84. Latin America Hepatitis B Human Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Hepatitis B Human Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Hepatitis B Human Immunoglobulin Sales by Application (2017-2022) & (Litre)
Table 87. Latin America Hepatitis B Human Immunoglobulin Sales by Application (2023-2028) & (Litre)
Table 88. Latin America Hepatitis B Human Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Hepatitis B Human Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Hepatitis B Human Immunoglobulin Sales by Country (2017-2022) & (Litre)
Table 91. Latin America Hepatitis B Human Immunoglobulin Sales by Country (2023-2028) & (Litre)
Table 92. Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Hepatitis B Human Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Type (2017-2022) & (Litre)
Table 95. Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Type (2023-2028) & (Litre)
Table 96. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Application (2017-2022) & (Litre)
Table 99. Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Application (2023-2028) & (Litre)
Table 100. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country (2017-2022) & (Litre)
Table 103. Middle East and Africa Hepatitis B Human Immunoglobulin Sales by Country (2023-2028) & (Litre)
Table 104. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Hepatitis B Human Immunoglobulin Revenue by Country (2023-2028) & (US$ Million)
Table 106. Biotest Corporation Information
Table 107. Biotest Description and Major Businesses
Table 108. Biotest Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 109. Biotest Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Biotest Recent Developments
Table 111. ADMA Biologics Corporation Information
Table 112. ADMA Biologics Description and Major Businesses
Table 113. ADMA Biologics Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 114. ADMA Biologics Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. ADMA Biologics Recent Developments
Table 116. Sanquin Blood Corporation Information
Table 117. Sanquin Blood Description and Major Businesses
Table 118. Sanquin Blood Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 119. Sanquin Blood Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Sanquin Blood Recent Developments
Table 121. Bio Products Laboratory Corporation Information
Table 122. Bio Products Laboratory Description and Major Businesses
Table 123. Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 124. Bio Products Laboratory Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Bio Products Laboratory Recent Developments
Table 126. Baxter Corporation Information
Table 127. Baxter Description and Major Businesses
Table 128. Baxter Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 129. Baxter Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Baxter Recent Developments
Table 131. CSL Corporation Information
Table 132. CSL Description and Major Businesses
Table 133. CSL Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 134. CSL Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. CSL Recent Developments
Table 136. Bayer Corporation Information
Table 137. Bayer Description and Major Businesses
Table 138. Bayer Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 139. Bayer Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Bayer Recent Developments
Table 141. Grifols Corporation Information
Table 142. Grifols Description and Major Businesses
Table 143. Grifols Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 144. Grifols Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Grifols Recent Developments
Table 146. Octapharma Corporation Information
Table 147. Octapharma Description and Major Businesses
Table 148. Octapharma Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 149. Octapharma Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Octapharma Recent Developments
Table 151. Hualan Biological Corporation Information
Table 152. Hualan Biological Description and Major Businesses
Table 153. Hualan Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 154. Hualan Biological Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Hualan Biological Recent Developments
Table 156. China Biologic Corporation Information
Table 157. China Biologic Description and Major Businesses
Table 158. China Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 159. China Biologic Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. China Biologic Recent Developments
Table 161. Tiantan Biologic Corporation Information
Table 162. Tiantan Biologic Description and Major Businesses
Table 163. Tiantan Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 164. Tiantan Biologic Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Tiantan Biologic Recent Developments
Table 166. Shuanglin Bio-pharmacy Corporation Information
Table 167. Shuanglin Bio-pharmacy Description and Major Businesses
Table 168. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 169. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Shuanglin Bio-pharmacy Recent Developments
Table 171. Sichuan Yuanda Shuyang Corporation Information
Table 172. Sichuan Yuanda Shuyang Description and Major Businesses
Table 173. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 174. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. Sichuan Yuanda Shuyang Recent Developments
Table 176. Shanghai Institute of Biological Corporation Information
Table 177. Shanghai Institute of Biological Description and Major Businesses
Table 178. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 179. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Shanghai Institute of Biological Recent Developments
Table 181. Hualan Corporation Information
Table 182. Hualan Description and Major Businesses
Table 183. Hualan Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 184. Hualan Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Hualan Recent Developments
Table 186. Shanghai RAAS Blood Products Corporation Information
Table 187. Shanghai RAAS Blood Products Description and Major Businesses
Table 188. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 189. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 190. Shanghai RAAS Blood Products Recent Developments
Table 191. China Grand Enterprises Corporation Information
Table 192. China Grand Enterprises Description and Major Businesses
Table 193. China Grand Enterprises Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 194. China Grand Enterprises Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 195. China Grand Enterprises Recent Developments
Table 196. Nanyue Biopharmaceutical Corporation Information
Table 197. Nanyue Biopharmaceutical Description and Major Businesses
Table 198. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 199. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 200. Nanyue Biopharmaceutical Recent Developments
Table 201. Boya Biopharmaceutical Group Corporation Information
Table 202. Boya Biopharmaceutical Group Description and Major Businesses
Table 203. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 204. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 205. Boya Biopharmaceutical Group Recent Developments
Table 206. Tonglu Biopharmaceutical Corporation Information
Table 207. Tonglu Biopharmaceutical Description and Major Businesses
Table 208. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 209. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 210. Tonglu Biopharmaceutical Recent Developments
Table 211. Shandong Taibang Biopharmaceutical Corporation Information
Table 212. Shandong Taibang Biopharmaceutical Description and Major Businesses
Table 213. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 214. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 215. Shandong Taibang Biopharmaceutical Recent Developments
Table 216. Guangdong Shuanglin Biopharmaceutical Corporation Information
Table 217. Guangdong Shuanglin Biopharmaceutical Description and Major Businesses
Table 218. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 219. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 220. Guangdong Shuanglin Biopharmaceutical Recent Developments
Table 221. Chengdu Rongsheng Pharmaceutical Corporation Information
Table 222. Chengdu Rongsheng Pharmaceutical Description and Major Businesses
Table 223. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 224. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 225. Chengdu Rongsheng Pharmaceutical Recent Developments
Table 226. Shenzhen Weiguang Biopharmaceutical Corporation Information
Table 227. Shenzhen Weiguang Biopharmaceutical Description and Major Businesses
Table 228. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 229. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 230. Shenzhen Weiguang Biopharmaceutical Recent Developments
Table 231. Green Cross (China) Biological Products Corporation Information
Table 232. Green Cross (China) Biological Products Description and Major Businesses
Table 233. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 234. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 235. Green Cross (China) Biological Products Recent Developments
Table 236. Sinopharm Corporation Information
Table 237. Sinopharm Description and Major Businesses
Table 238. Sinopharm Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$ Million), Price (US$/ML) and Gross Margin (2017-2022)
Table 239. Sinopharm Hepatitis B Human Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 240. Sinopharm Recent Developments
Table 241. Key Raw Materials Lists
Table 242. Raw Materials Key Suppliers Lists
Table 243. Hepatitis B Human Immunoglobulin Distributors List
Table 244. Hepatitis B Human Immunoglobulin Customers List
Table 245. Hepatitis B Human Immunoglobulin Market Trends
Table 246. Hepatitis B Human Immunoglobulin Market Drivers
Table 247. Hepatitis B Human Immunoglobulin Market Challenges
Table 248. Hepatitis B Human Immunoglobulin Market Restraints
Table 249. Research Programs/Design for This Report
Table 250. Key Data Information from Secondary Sources
Table 251. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatitis B Human Immunoglobulin Product Picture
Figure 3. Global Hepatitis B Human Immunoglobulin Market Share by Type in 2021 & 2028
Figure 3. 100IU Product Picture
Figure 4. 200IU Product Picture
Figure 5. 400IU Product Picture
Figure 6. Global Hepatitis B Human Immunoglobulin Market Share by Application in 2021 & 2028
Figure 7. Measles Prevention
Figure 8. Prevention of Hepatitis B Virus Infection
Figure 9. Hepatitis A Virus Infection
Figure 10. Other
Figure 11. Hepatitis B Human Immunoglobulin Report Years Considered
Figure 12. Global Hepatitis B Human Immunoglobulin Sales 2017-2028 (Litre)
Figure 13. Global Hepatitis B Human Immunoglobulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Hepatitis B Human Immunoglobulin Revenue 2017-2028 (US$ Million)
Figure 15. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2017-2022)
Figure 17. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2023-2028)
Figure 18. North America Hepatitis B Human Immunoglobulin Sales YoY (2017-2028) & (Litre)
Figure 19. North America Hepatitis B Human Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Hepatitis B Human Immunoglobulin Sales YoY (2017-2028) & (Litre)
Figure 21. Europe Hepatitis B Human Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Hepatitis B Human Immunoglobulin Sales YoY (2017-2028) & (Litre)
Figure 23. Asia-Pacific Hepatitis B Human Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Hepatitis B Human Immunoglobulin Sales YoY (2017-2028) & (Litre)
Figure 25. Latin America Hepatitis B Human Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Hepatitis B Human Immunoglobulin Sales YoY (2017-2028) & (Litre)
Figure 27. Middle East & Africa Hepatitis B Human Immunoglobulin Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Hepatitis B Human Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Hepatitis B Human Immunoglobulin in the World: Market Share by Hepatitis B Human Immunoglobulin Revenue in 2021
Figure 30. Global Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 32. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 33. Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 34. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 35. North America Hepatitis B Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 36. North America Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 37. North America Hepatitis B Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 38. North America Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 39. North America Hepatitis B Human Immunoglobulin Sales Share by Country (2017-2028)
Figure 40. North America Hepatitis B Human Immunoglobulin Revenue Share by Country (2017-2028)
Figure 41. U.S. Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Hepatitis B Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 44. Europe Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 45. Europe Hepatitis B Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 46. Europe Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 47. Europe Hepatitis B Human Immunoglobulin Sales Share by Country (2017-2028)
Figure 48. Europe Hepatitis B Human Immunoglobulin Revenue Share by Country (2017-2028)
Figure 49. Germany Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 50. France Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Hepatitis B Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Hepatitis B Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Hepatitis B Human Immunoglobulin Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Hepatitis B Human Immunoglobulin Revenue Share by Region (2017-2028)
Figure 60. China Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 63. India Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Hepatitis B Human Immunoglobulin Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Hepatitis B Human Immunoglobulin Sales Market Share by Type (2017-2028)
Figure 71. Latin America Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Hepatitis B Human Immunoglobulin Sales Market Share by Application (2017-2028)
Figure 73. Latin America Hepatitis B Human Imm
